The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve ...

One ALS patient received TRE-515 under the FDA program last year, and early signs suggest the therapy may help stabilize ...

The new project combines clinical data with advanced analytics and artificial intelligence in an effort to create ...

ALS is life‑changing, but new treatments, specialized care, and innovative research are bringing real hope. See how advances at University of Utah Health are shaping the future of ALS care.

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new ...

Brooke Eby, a writer, speaker, and social media creator who lives with ALS, has been named ALS Network's Advocate of the Year. Through her advocacy work, Eby has increased awareness and raised more ...

A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery - current cell models used for ...

Michele Stellato, 37, and Mira Hudson, 29, are part of a largely unseen group: young women with neurodegenerative disease ALS. They joined and eventually became leaders of Her ALS Story, a support and ...

Former Premier League footballer Petter Rudi diagnosed with ALS - Petter Rudi played in the Premier League for Sheffield ...

Eric Dane, known for his roles on “Grey’s Anatomy” and “Euphoria,” died this week from amyotrophic lateral sclerosis at age 53. The fatal nervous system disease, also known as Lou Gehrig’s disease, ...